Market Place
Sourcing Support
UK MHRA grants Mkt approval for ViiV`s cabotegravir formulations prevent HIV-1
04 May 2024 //
PHARMABIZ
FDA approves first extended-release injectable, complete regimen for HIV
22 Jan 2021 //
EUROPEANPHARMACEUTICALREVIEW
GSK`s ViiV nabs first approval for HIV game-changer Cabenuva
21 Mar 2020 //
FIERCE PHARMA
Positive Recommendation by NICE for first anti-CGRP migraine therap
12 Mar 2020 //
BUSINESSWIRE
FDA slams GSK`s monthly HIV injectable with CRL, citing manufacturing issues
24 Dec 2019 //
ENDPTS
ViiV inks bNAb deal with National Institutes of Health
22 Nov 2019 //
PHARMA TIMES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.